Literature DB >> 14680418

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Stephen R Marder1, Robert Conley, Larry Ereshefsky, John M Kane, Martin S Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14680418

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  8 in total

1.  Evaluating appropriateness of prescribing of long-acting risperidone for injection in acute care settings.

Authors:  Greg T Mah; Jane Dumontet; Anisha Lakhani; Susan Corrigan
Journal:  Can J Hosp Pharm       Date:  2010-11

2.  Long-acting risperidone in the treatment of schizophrenia: an evidence-based approach.

Authors:  Maju Mathews; Babatunde Adetunji; Jamal Mahmud; Vinu George; Mathews Thomas; Sunil Joseph
Journal:  Psychiatry (Edgmont)       Date:  2005-02

3.  A review of pharmacologic strategies for switching to atypical antipsychotics.

Authors:  Prakash S Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 4.  Long-acting risperidone: a review of its use in schizophrenia.

Authors:  Tracy Swainston Harrison; Karen L Goa
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.

Authors:  Hans-Jürgen Möller
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics.

Authors:  Pierre Chue; Robin Emsley
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial.

Authors:  Joseph Ventura; Kenneth L Subotnik; Denise Gretchen-Doorly; Laurie Casaus; Michael Boucher; Alice Medalia; Morris D Bell; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2017-11-09       Impact factor: 4.662

8.  Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.

Authors:  Pierre Chue
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.